Association between Serum Vitamin D levels and the Atherogenic index of plasma, among patients with Type II Diabetes Mellitus, A Cross Sectional Study

Introduction: The Vitamin D deficiency and insufficiency is a wide spread global health issue, highly prevalent, regardless of age, gender, and country of origin. Vitamin D is known to regulate insulin secretion and synthesis by beta cells of pancreas, thus deficiency contributes to development of Diabetes Mellitus. Apart from glycaemic control, vitamin D is also involved in lipid metabolism. The low levels of vitamin D, enables vascular inflammation, endothelial dysfunction, foam cell formation and smooth muscle proliferation. Increasing circulating vitamin D levels, has been found to reduce the risk of hypertension, stroke, and myocardial infarction effectively. Dyslipidaemia, an important public health problem, is an independent risk factor for cardiovascular disease. The vitamin D has an inverse association with LDL cholesterol, contributing to the development of dyslipidaemia in deficiency. AIM: To evaluate the association between serum vitamin D levels and the Atherogenic index of plasma (AIP), among patients with Type II Diabetes Mellitus. Materials and methods: This analytical cross-sectional study was conducted in the Department of Biochemistry, Mamata Academy of Medical Sciences, Bachupally, Hyderabad, Telangana, from January 2026 to June 2026. A total of 152 subjects were included in the study, comprising 76 individuals with Type 2 Diabetes Mellitus (T2DM) and 76 healthy controls. Glycemic control was assessed by measuring glycosylated hemoglobin (HbA1c) by high performance liquid chromatography (HPLC), while serum vitamin D levels were estimated using the chemiluminescent immunoassay (CLIA) method. Dyslipidaemia indices were calculated from lipid profile parameters, including total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and verylow-density lipoprotein cholesterol (VLDL-C). Statistical analyses were performed using RStudio version 4.5.1 (202506-13 ucrt). The differences in HbA1c, serum vitamin D levels, and dyslipidaemia indices between the study groups were assessed using the Mann–Whitney U test. The associations between serum vitamin D, HbA1c, and dyslipidaemia indices were evaluated using Spearman’s rank correlation analysis. Conclusion: Patients with Type 2 Diabetes Mellitus (T2DM) and poor glycaemic control may have an increased atherogenic risk, suggesting that HbA1c may serve as a useful marker for assessing cardiovascular risk in this population. The vitamin D deficiency is associated with poor glycemic control and atherogenic dyslipidemia. Therefore, improving vitamin D status as an important indicator may alleviate AIP as a surrogate marker for predicting the risk of cardiovascular events in healthy population.

Authors

Institutions

Publication Details

Journal
International Journal of Drug Delivery Technology
Published
2026-11-17
DOI
https://doi.org/10.25258/ijddt.16.80s.111
Primary Topic
Vitamin D Research Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Association between Serum Vitamin D levels and the Atherogenic index of plasma, among patients with Type II Diabetes Mellitus, A Cross Sectional Study

D Vinay Babu, S Prasanna, Shilpa Joshi
1 links
International Journal of Drug Delivery Technology
Vitamin D Research Studies
article

Association between Serum Vitamin D levels and the Atherogenic index of plasma, among patients with Type II Diabetes Mellitus, A Cross Sectional Study

D Vinay Babu, S Prasanna, Shilpa Joshi
article en

Abstract

Introduction: The Vitamin D deficiency and insufficiency is a wide spread global health issue, highly prevalent, regardless of age, gender, and country of origin. Vitamin D is known to regulate insulin secretion and synthesis by beta cells of pancreas, thus deficiency contributes to development of Diabetes Mellitus. Apart from glycaemic control, vitamin D is also involved in lipid metabolism. The low levels of vitamin D, enables vascular inflammation, endothelial dysfunction, foam cell formation and smooth muscle proliferation. Increasing circulating vitamin D levels, has been found to reduce the risk of hypertension, stroke, and myocardial infarction effectively. Dyslipidaemia, an important public health problem, is an independent risk factor for cardiovascular disease. The vitamin D has an inverse association with LDL cholesterol, contributing to the development of dyslipidaemia in deficiency. AIM: To evaluate the association between serum vitamin D levels and the Atherogenic index of plasma (AIP), among patients with Type II Diabetes Mellitus. Materials and methods: This analytical cross-sectional study was conducted in the Department of Biochemistry, Mamata Academy of Medical Sciences, Bachupally, Hyderabad, Telangana, from January 2026 to June 2026. A total of 152 subjects were included in the study, comprising 76 individuals with Type 2 Diabetes Mellitus (T2DM) and 76 healthy controls. Glycemic control was assessed by measuring glycosylated hemoglobin (HbA1c) by high performance liquid chromatography (HPLC), while serum vitamin D levels were estimated using the chemiluminescent immunoassay (CLIA) method. Dyslipidaemia indices were calculated from lipid profile parameters, including total cholesterol (TC), triglycerides (TG), low-density lipoprotein cholesterol (LDL-C), high-density lipoprotein cholesterol (HDL-C), and verylow-density lipoprotein cholesterol (VLDL-C). Statistical analyses were performed using RStudio version 4.5.1 (202506-13 ucrt). The differences in HbA1c, serum vitamin D levels, and dyslipidaemia indices between the study groups were assessed using the Mann–Whitney U test. The associations between serum vitamin D, HbA1c, and dyslipidaemia indices were evaluated using Spearman’s rank correlation analysis. Conclusion: Patients with Type 2 Diabetes Mellitus (T2DM) and poor glycaemic control may have an increased atherogenic risk, suggesting that HbA1c may serve as a useful marker for assessing cardiovascular risk in this population. The vitamin D deficiency is associated with poor glycemic control and atherogenic dyslipidemia. Therefore, improving vitamin D status as an important indicator may alleviate AIP as a surrogate marker for predicting the risk of cardiovascular events in healthy population.

International Journal of Drug Delivery TechnologyVol. 16(80s)
Mamata Medical College (IN)
Good health and well-being
Vitamin D Research Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon